AI assistant
Cytosorbents Corp — Director's Dealing 2024
Apr 3, 2024
34501_dirs_2024-04-02_8b690871-b60a-406b-828f-2c777948cdd6.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Cytosorbents Corp (CTSO)
CIK: 0001175151
Period of Report: 2024-03-29
Reporting Person: BLOCH KATHLEEN P. (Chief Financial Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-03-29 | Stock Option (Right to Buy) | $0.95 | A | 49038 | Acquired | 2034-03-29 | Common Stock (49038) | Direct |
Footnotes
F1: The reporting person participated in a voluntary salary reduction for the period from April 1, 2024, to December 31, 2024, and these stock
options were granted in connection with the salary reduction. These stock options were issued pursuant to the Amended and Restated CytoSorbents Corporation 2014 Long-Term Incentive Plan. The shares underlying these stock options will vest fully on January 31, 2025, except as set forth on the corresponding non-qualified stock option agreement and subject to the reporting person's continued service as of the applicable vesting date.